John Colgrove

John Colgrove sells 100,000 shares at $79.82 blended price; -19.8% below 52-week high; 10b5-1 plan.

Chief Visionary Officer John Colgrove sold 100,000 shares (100.0K shares) totaling $7,982,329.01 via 8 separate sales on 2026-07-10, reducing his holdings from 2.66M to 2.56M shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-01-08, meaning the sale was scheduled rather than discretionary. At the blended average price of $79.82, the sale occurred 19.8% below the 52-week high of $93.92, with the current stock price at $75.36. The company's fundamentals show annual revenue growth of 15.6% and a P/E of 110.82, though the elevated valuation multiple deserves attention. His prior trades at this ticker (5 prior sales) generated positive 30-day returns ranging from 10.9% to 13.3%, though outcomes beyond 30 days remain unmeasurable.

CVO John Colgrove sold 100,000 shares for $7.1M at blended avg $71.04 under 10b5-1 plan; retains 2.62M shares post-sale.

John Colgrove executed 5 separate sales totaling 100,000 shares for $7,103,769.46 at prices ranging from $70.00 to $71.54, representing a -3.7% reduction in his holdings to 2,615,000 shares. The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2026-01-08, indicating the sales were scheduled rather than discretionary. Stock price has declined -14.4% over the past 30 days and stands -23.0% from its 52-week high of $93.92, though his prior 5 same-ticker sales at this company all occurred on 2026-05-11 and showed 30-day post-sale declines ranging from -23.0% to -25.4%. The scheduled nature of this transaction removes any timing signal; investors should note the pattern of post-sale price weakness in his prior same-ticker trades but recognize this filing reflects a programmatic disposition plan rather than a discretionary market judgment.

Everpure Chief Visionary Officer John Colgrove executes 10b5-1 plan: 100,000 shares for $8.8M at blended $87.82

John Colgrove executed 20 separate sales totaling 100,000 shares for $8,781,932.87 on 2026-05-11 under a pre-arranged 10b5-1 trading plan adopted on 2026-01-08. This was a scheduled, non-discretionary disposition, reducing his post-transaction holdings to 2,665,000 shares (a -3.6% net change from pre-transaction holdings). The transaction occurred across a range of prices from $83.84 to $93.42, with a blended average of $87.82, slightly above the current price of $84.43 as of 2026-05-13. The recent IPO status of Everpure (18 trading days post-listing) and the high P/E of 131.92 against solid fundamentals—$964.5M quarterly revenue with +15.6% annual growth and $54.8M net income—provide context for the sale, though the 10b5-1 framework removes discretion from the timing.

CVO John Colgrove sold 134,265 shares over 3 days (May 5-7) for $10,088,483.74 at avg $75.14; retains 467,694 shares post-sale.

Colgrove executed 3 separate sales totaling 134,265 shares for $10,088,483.74 across May 5–7, 2026, reducing his stake by -22.3% versus pre-transaction holdings of 601,959 shares. The transaction prices ($75.12, $75.01, $75.31) clustered tightly around the blended average of $75.14, which compares closely to the current price of $74.43 as of 2026-05-06. The stock is a recent listing (14 trading days), limiting historical context; valuations remain elevated (P/E 130.58) relative to revenue growth (+15.6% annually) and profitability ($87.9M net income on $2.6B revenue). The large absolute dollar sale ($10.1M) by a Chief Visionary Officer warrants investor attention to motivation and timing context, though this filing alone does not resolve whether the sale reflects portfolio rebalancing or broader business signal.

Director liquidates complete stake in Everpure via large sale near 52-week highs

A director has sold their entire shareholding in Everpure, disposing of roughly twenty-nine thousand shares at a price near the company's recent peak. This complete exit is noteworthy because it signals the insider is stepping away entirely rather than making a routine rebalancing trade. The company itself is profitable with strong revenue growth and a track record of financial performance, which could suggest the insider is simply taking chips off the table at a favorable price rather than fleeing weakness. However, the stock's valuation appears stretched relative to earnings, which may have factored into the decision to sell at current levels. The timing—at or very near 52-week highs—is the critical detail: insiders typically liquidate when they view valuations as attractive, not when they're concerned about fundamental deterioration.

Chief Visionary Officer John Colgrove sold 100,000 shares ($6.0M) via scheduled 10b5-1 plan at PSTG over four days.

John Colgrove, Chief Visionary Officer of Pure Storage, executed 4 separate sales totaling 100,000 shares for $6,012,759.48 (blended average $60.13) between 2025-07-29 and 2025-07-31. This reduction represents a 12.5% decline in his holdings, from 801,959 shares to 701,959 shares post-transaction. The filing is flagged as part of a pre-arranged 10b5-1 trading plan adopted on 2025-01-07, indicating these sales were scheduled and not discretionary. The systematic execution across multiple days and consistent pricing suggests orderly plan-based liquidation rather than a concentrated directional bet. With no additional context on company fundamentals or prior trading patterns, this represents routine execution of a pre-established plan.

Chief Visionary Officer Colgrove sells 100,000 shares of PSTG at $52.01; stock now $56.44, down 16.4% in 90 days

Colgrove sold 100,000 shares (100.0K shares) of Pure Storage at $52.01 on 2025-05-12, representing an 11.1% reduction of his pre-transaction holdings of 901,959 shares. The sale occurred near a depressed point in the stock's 52-week range: $52.01 sits 22.0% below the 52-week high of $72.37, though the stock has recovered 36.8% over the past 30 days. Colgrove's prior trades at PSTG show a consistent 90-day timing pattern: all 5 prior sales at this ticker were well-timed (negative 90-day returns ranging from -18.0% to -25.8%), indicating he has systematically sold PSTG into weakness that precedes further declines. However, the current 90-day return since his transaction on 2025-05-12 is -16.4%, which continues this pattern and tracks with his historical accuracy at this specific ticker. The company's fundamentals show revenue of $831.1M and net income of $63.6M, though the P/E of 104.52 reflects elevated valuation. This sale occurs within a larger pattern of disciplined positioning rather than isolated circumstance.